Creative Planning
TRIL

Creative Planning’s Trillium Therapeutics Inc. TRIL Stock Holding History

Creative Planning’s Portfolio TRIL Stock Details TRIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-10,400
Closed -$101K – 2254
2021
Q2 		$101K Sell
10,400
-10,650
-51% -$100K ﹤0.01% 1871
2021
Q1 		$226K Sell
21,050
-24,758
-54% -$306K ﹤0.01% 1999
2020
Q4 		$674K Buy
45,808
+27,212
+146% +$392K ﹤0.01% 1148
2020
Q3 		$264K Buy
18,596
+6,371
+52% +$63.5K ﹤0.01% 1503
2020
Q2 		$99K Buy
+12,225
New +$75.6K ﹤0.01% 1665
2018
Q4 		– Sell
-29,300
Closed -$170K – 2159
2018
Q3 		$170K Sell
29,300
-100
-0.3% -$564 ﹤0.01% 1707
2018
Q2 		$176K Buy
29,400
+1,000
+4% +$6.38K ﹤0.01% 1670
2018
Q1 		$204K Buy
28,400
+2,000
+8% +$15.2K ﹤0.01% 1608
2017
Q4 		$191K Hold
26,400
– – ﹤0.01% 1621
2017
Q3 		$136K Hold
26,400
– – ﹤0.01% 1677
2017
Q2 		$116K Buy
26,400
+300
+1% +$1.66K ﹤0.01% 1890
2017
Q1 		$161K Hold
26,100
– – ﹤0.01% 1629
2016
Q4 		$147K Buy
26,100
+18,000
+222% +$179K ﹤0.01% 1591
2016
Q3 		$120K Buy
8,100
+2,200
+37% +$25.3K ﹤0.01% 1725
2016
Q2 		$53K Buy
5,900
+5,800
+5,800% +$60.3K ﹤0.01% 2109
2016
Q1 		$1K Hold
100
– – ﹤0.01% 4209
2015
Q4 		$1K Sell
100
-9,400
-99% -$131K ﹤0.01% 4287
2015
Q3 		$124K Buy
+9,500
New +$175K ﹤0.01% 1471

Other funds holding TRIL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
OPU
Omni Partners US Irvine, California $1.95B AUM
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
VI
Versor Investments New York $40.8M AUM 93.59% 1-Year Est. Return

Creative Planning's TRIL Position: Q3 2021 in Review

Creative Planning sold out of Trillium Therapeutics Inc. (TRIL) in Q3 2021, closing a stake of 10,400 shares — an estimated $101K sold.

Creative Planning first reported a position in TRIL in Q3 2015 and held it in 18 quarters. The position peaked at $674K in Q4 2020. 181 funds tracked by Wall St. Rank hold TRIL as of Q3 2021.

  • Creative Planning reported no remaining Trillium Therapeutics Inc. position as of Q3 2021 after selling out during the quarter.
  • Creative Planning sold 10,400 Trillium Therapeutics Inc. shares in Q3 2021, an estimated $101K.
  • Creative Planning first reported a position in Trillium Therapeutics Inc. in Q3 2015 and held it in 18 quarters.
  • Creative Planning's Trillium Therapeutics Inc. position peaked at $674K in Q4 2020.
  • 181 funds tracked by Wall St. Rank held Trillium Therapeutics Inc. as of Q3 2021.

Based on Creative Planning's 13F filing for Q3 2021, filed 10 Nov 2021.